Stifel analysts have maintained a Buy rating and a $28.00 price target for Phathom Pharmaceuticals (NASDAQ:PHAT), focusing on the company's recent developments. Currently trading at $5.59, ...

Eton Pharmaceuticals (ETON) announced that the United States Patent and Trademark Office has granted the company U.S. Patent No. 12,214,010, ...

Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange ...

The Clearwater County Historical Society will hold a used book sale Feb. 11-19, at the History Center in Shevlin. The sale will run from 10 a.m. to 4 p.m. Tuesday through Friday, 10 a.m. to 2 p.m. on ...

With mounting research on health risks and regulatory bans, the food industry is rethinking its approach to color.

The state of California banned the Red No. 3 dye and three other food additives in 2023, which gave manufacturers until 2027 ...

Exciting news: metro.news has merged with metro.co.uk! That means that as well as keeping up with all the latest news and features you love from Metro Newspaper you’ll also be joining the 23 ...

The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...

Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

Leerink Partners analyst Faisal Khurshid has reiterated their bullish stance on GERN stock, giving a Buy rating yesterday.Invest with ...

Precedential and Key Federal Circuit Opinions - TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. v. AMNEAL PHARMACEUTICALS OF NEW ...